Statements (65)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:medical_devices
|
| gptkbp:acquired_by |
Stryker Corporation in 2020
|
| gptkbp:acquisition |
gptkb:Stryker_Corporation
targeting complementary companies |
| gptkbp:acquisition_year |
gptkb:2020
|
| gptkbp:business_model |
B2 B and B2 C
|
| gptkbp:ceo |
Robert Palmisano
|
| gptkbp:clinical_trial |
ongoing
supporting product efficacy |
| gptkbp:community_engagement |
local healthcare initiatives
|
| gptkbp:customer_base |
hospitals and clinics
|
| gptkbp:customer_feedback |
integrated into product development
|
| gptkbp:customer_support |
dedicated support teams
|
| gptkbp:employees |
approximately 1,500
|
| gptkbp:financial_performance |
strong growth
|
| gptkbp:financial_reports |
available online
|
| gptkbp:focus |
innovative solutions for extremities and biologics
|
| gptkbp:focus_area |
orthopedic surgery
|
| gptkbp:founded |
1950
|
| gptkbp:global_presence |
over 60 countries
|
| gptkbp:governance |
transparent practices
|
| gptkbp:headcount |
around 1,500
|
| gptkbp:headquarters |
gptkb:Amsterdam,_Netherlands
gptkb:Amsterdam |
| https://www.w3.org/2000/01/rdf-schema#label |
Wright Medical Group N. V.
|
| gptkbp:industry |
gptkb:medical_devices
|
| gptkbp:innovation |
focus on new technologies
|
| gptkbp:invention |
numerous
|
| gptkbp:investment |
publicly traded
in technology and innovation focus on maximizing |
| gptkbp:market |
global
ongoing analysis of trends |
| gptkbp:market_cap |
approximately $3 billion
|
| gptkbp:market_launch |
regularly scheduled
|
| gptkbp:marketing_strategy |
expansion in emerging markets
|
| gptkbp:partnerships |
various healthcare providers
with research institutions |
| gptkbp:product |
patient-centered design
|
| gptkbp:product_line |
shoulder, elbow, wrist, hand, hip, knee, ankle
|
| gptkbp:product_quality |
high standards
|
| gptkbp:products |
orthopedic implants
|
| gptkbp:regulatory_compliance |
FDA approved
|
| gptkbp:research_and_development |
significant investment
|
| gptkbp:revenue |
$1 billion (2020)
|
| gptkbp:risk_management |
comprehensive strategies
|
| gptkbp:safety_measures |
high industry standards
|
| gptkbp:sales |
increasing year over year
|
| gptkbp:social_responsibility |
community health programs
|
| gptkbp:specializes_in |
lower extremity reconstruction
upper extremity reconstruction |
| gptkbp:stock_symbol |
WMGI
|
| gptkbp:strategic_goals |
long-term growth
|
| gptkbp:subsidiary |
Wright Medical Technology, Inc.
|
| gptkbp:supply_chain |
global suppliers
|
| gptkbp:sustainability_initiatives |
environmental responsibility
|
| gptkbp:traded_on |
gptkb:NASDAQ
|
| gptkbp:training |
ongoing education programs
|
| gptkbp:training_programs |
for healthcare professionals
|
| gptkbp:treatment |
improved patient outcomes
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:type_of_business |
robust plans in place
|
| gptkbp:website |
www.wright.com
|
| gptkbp:bfsParent |
gptkb:SYK
|
| gptkbp:bfsLayer |
6
|